Congress has passed the MATE Act requiring all healthcare providers with prescriptive authority to complete a one-time training (totaling 8 hours) on managing patients with substance use disorders.
- Education to meet new DEA requirements.
- Earn 8 Class A CE and 8 pharmacology credits while fulfilling new DEA requirements.
- Prevent, recognize, and care for patients with substance use disorders.
- Through AANA's accreditation with the American Nurses Credentialing Center (ANCC), AANA meets the requirements able to offer these CE credits.
Bundle Course Offerings:
- Making a Difference with the Substance Use Disorder Patient: An Overview of the Disease, Refocusing our Paradigm, and Nurse Anesthesiology Advocacy for the Patient -- This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1043348; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 1.00 CE Credits in pharmacology/therapeutics.
- Racial and Ethnic Disparities in Acute Perioperative Pain Management -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043349; Expiration Date 6/6/2027. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.
- Perioperative Management of Patients on Maintenance Medication for Addiction Treatment: The Development of an Institutional Guideline -- This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1043350; Expiration Date 6/6/2027. AANA designates this program as meeting the criteria for up to 1.00 CE Credits in pharmacology/therapeutics.
- A Predictive Model for Developing Long-Term Opioid Use After Neuosurgery and Orthopedic Surgery -- This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1043351; Expiration Date 3/18/2027. AANA designates this program as meeting the criteria for up to 1.00 CE Credits in pharmacology/therapeutics.
- Anesthesia Pain Management Strategies for Parturients on Medication Assisted Treatment -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043352; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.
- Analgesia and Anesthesia for the Substance Use Disorder Patient -- This program has been prior approved by the American Association of Nurse Anesthesiology for 1.00 Class A CE credits; Code Number 1043353; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 1.00 CE Credits in pharmacology/therapeutics.
- Fentanyl: Emerging Threats and Harm Reduction Strategies for SUD -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043356; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.
- Low Threshold Treatment for Opioid Use Disorder -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043357; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.
- Reducing Opioid Use Disorder (OUD) Stigma -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043366; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.
- Medication for Opioid Use Disorder (MOUD) -- This program has been prior approved by the American Association of Nurse Anesthesiology for 0.5 Class A CE credits; Code Number 1043367; Expiration Date 6/6/2026. AANA designates this program as meeting the criteria for up to 0.5 CE Credits in pharmacology/therapeutics.